Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
---|
01/23/2007 | US7166707 Identifying peptide mimetic for treatment and prevention of tumors and autoimune diseases |
01/23/2007 | US7166641 Diclofenac salt of lidocaine |
01/23/2007 | US7166639 Blocking activation of transcription factor; aminothiophene compound; tissue repair; antiarthritic agents; inflammatory bowel disorders; antihistamines;; osteoporosis; skin disorders; autoimmune diseases |
01/23/2007 | US7166631 E-series of prostaglandin (EP) receptors; e.g [[4-(4,9-dipropoxy-1-oxo-1,3-dihydro-2H-benzo[f]isoindol-2-yl) phenyl]acetic acid |
01/23/2007 | US7166628 Inflammation such as chronic inflammatory disease. Also disclosed are processes for preparing these compounds and pharmaceutical compositions comprising these compounds. Ar1 is carbocycle optionally substituted with one R1, and wherein Ar1 |
01/23/2007 | US7166625 Method for treating fibrotic diseases and other indications |
01/23/2007 | US7166623 Pain and inflammation |
01/23/2007 | US7166618 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use |
01/23/2007 | US7166616 Substituted alkanoic acids |
01/23/2007 | US7166614 CCR-2 modulators; INFLAMMATORY, IMMUNOREGULATORY, ALLERGIC, AND AUTOIMMUNE DISORDERS AND DISEASES |
01/23/2007 | US7166605 Prophylaxis; endothelial diseases, oxidative stress, cardiovascular, inflammatory, cardiovascular, ocular, autoimmune diseases, neurological disorders and cancer, hypercholesterolemia and hyperlipidemia |
01/23/2007 | US7166598 Piperazine derivatives |
01/23/2007 | US7166597 Antiinflammatory agents; autoimmune disease treatments; pyrazolo(1,5-a)pyridine derivatives |
01/23/2007 | US7166593 Glucocorticoid receptor modulators |
01/23/2007 | US7166592 Antiinflammatory agents |
01/23/2007 | US7166586 Sulfonamide lactam inhibitors of FXa and method |
01/23/2007 | US7166583 1,3-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
01/23/2007 | US7166568 Compositions and methods to inhibit formation of the C5b-9 complex of complement |
01/23/2007 | US7166467 Nucleic acids, polypeptides, compositions, and methods for modulating apoptosis |
01/23/2007 | US7166455 A genetic engineered nuclear acids, culturing Bacteroides fragilis, encoding immunomodulator, treating inflammatory bowel disease |
01/23/2007 | US7166297 Comprises liposomes attached to prodrugs through phosphonate linkages; phospholipases; targets liver/spleen |
01/23/2007 | US7166293 Anticancer agents; antitumor agents; cardiovascular diosrders; antiinflammatory agents |
01/23/2007 | CA2329193C Process for synthesizing cox-2 inhibitors |
01/23/2007 | CA2269946C Naphthyridine derivatives |
01/23/2007 | CA2191747C (a)-annelated pyrrole derivatives and pharmaceutical use thereof |
01/18/2007 | WO2007008119A1 The use of ketoprofen in treating hemorrhoids |
01/18/2007 | WO2007007890A1 N-dihydroxyalkyl-substituted 2-oxoimidazole derivative |
01/18/2007 | WO2007007778A1 Benzoimidazole compound capable of inhibiting prostaglandin d synthetase |
01/18/2007 | WO2007007732A1 Agent for elevating adiponectin concentration |
01/18/2007 | WO2007007524A1 Inhibitor of enzymatic activity of macrophage migration inhibitory factor |
01/18/2007 | WO2007007162A1 New combination of anti-madcam antibody and antifibrotic caspase inhibitor to treat liver fibrosis |
01/18/2007 | WO2007007160A2 Anti-madcam antibodies to treat fever |
01/18/2007 | WO2006120010A3 Dibenzocycloheptane compounds and pharmaceuticals containing these compounds |
01/18/2007 | WO2006014381A3 Use of thioflavin radiolabeled derivatives in amyloid imaging gor assessing anti-amyloid therapies |
01/18/2007 | WO2005097192A9 Active substance combination of a carbinol compound and an opioid |
01/18/2007 | US20070015819 Novel compounds |
01/18/2007 | US20070015775 Heterocyclic compounds |
01/18/2007 | US20070015772 Nucleoside metabolism inhibitors |
01/18/2007 | US20070015766 Quinoline Derivatives as NK-3 and NK-2 Antagonists |
01/18/2007 | US20070015755 Novel compounds and compositions as protease inhibitors |
01/18/2007 | US20070015257 Alpha-MSH related compounds and methods of use |
01/18/2007 | US20070015219 Specifically binds an MK61 polypeptide produced by immunizing an animal |
01/18/2007 | US20070014861 Treatment of proctitis |
01/18/2007 | US20070014860 Treatment of esophagitis |
01/18/2007 | US20070014840 Circular dumbbell decoy oligodeoxynucleotides (cdodn) containing dna bindings sites of transcription |
01/18/2007 | US20070014816 such as a botulinum toxin; pain is not associated with a headache pain |
01/18/2007 | US20070014737 Administering quinine, chlorzoxazone, cyclobenzaprine, carisoprodol via vaporization |
01/18/2007 | DE3915617B4 Verwendung einer ein Cyclosporin enthaltenden Zusammensetzung zur topischen Applikation Use of a composition containing a cyclosporin for topical application |
01/18/2007 | CA2614754A1 Pharmaceutical compositions comprising a tgf-beta superfamily member |
01/18/2007 | CA2614688A1 N-dihydroxyalkyl-substituted 2-oxo-imidazole derivatives |
01/18/2007 | CA2614622A1 New combination of anti-madcam antibody and antifibrotic caspase inhibitor to treat liver fibrosis |
01/18/2007 | CA2614147A1 Benzoimidazole compound capable of inhibiting prostaglandin d synthetase |
01/17/2007 | EP1743945A1 Screening method |
01/17/2007 | EP1743944A1 Novel method of screening |
01/17/2007 | EP1743891A1 Heterocyclic compounds and methods for modulating CXCR3 function |
01/17/2007 | EP1743885A2 TNF-Alpha Produktion Hemmer zur Behandlung von Autoimmunerkrankungen |
01/17/2007 | EP1743657A2 Stabilisation of macrolides |
01/17/2007 | EP1743655A1 Combinations comprising dipeptidylpeptidase-IV inhibitors and antidiabetic agents |
01/17/2007 | EP1743635A2 Gibberellins for the promotion of ulcer healing |
01/17/2007 | EP1743632A1 Novel 4-dedimethy laminotetracycline derivatives |
01/17/2007 | EP1742944A1 Indoles, 1h-indazoles, 1,2-benzisoxazoles, 1,2-benzoisothiazoles, and preparation and uses thereof |
01/17/2007 | EP1742932A1 3-heterocyclyl-4-phenyl-triazole derivatives as inhibitors of the vasopressin v1a receptor |
01/17/2007 | EP1742922A1 Crystalline pyrazole derivative |
01/17/2007 | EP1742916A1 Phenyl compounds and their use in the treatment of conditions mediated by the action of pge2 at the ep1 receptor |
01/17/2007 | EP1537110B1 Triazospiro compounds having nociceptin receptor affinity |
01/17/2007 | EP1532148B1 Novel purine- or pyrrolol(2,3-d)pyrimidine-2-carbonitiles for treating diseases associated with cysteine protease activity |
01/17/2007 | EP1432445B1 Treatment of chronic joint inflammation using an antibody against the cd3 antigen complex |
01/17/2007 | EP1392309B1 Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands |
01/17/2007 | EP1301539B1 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
01/17/2007 | EP1272160B1 Lipid-based drug delivery systems for topical application |
01/17/2007 | EP1268783B9 Antiangiogene Eigenschaften von Matin und Fragmenten oder Varianten davon |
01/17/2007 | EP1268444B1 2,4-di(hetero-)arylamino(-oxy)-5-substituted pyrmidines as antineoplastic agents |
01/17/2007 | EP1223977B1 Modified plant viruses and methods of use thereof |
01/17/2007 | EP1180518B1 5-pyridyl-1,3-azole compounds, process for producing the same and use thereof |
01/17/2007 | EP1140174B1 Antagonist antibodies of cutaneous t cell-attracting chemokine (ctack) or vasoactive intestinal contractor (vic) chemokines |
01/17/2007 | CN1898243A Bicyclic heterocyclic p-38 kinase inhibitors |
01/17/2007 | CN1898204A 2-(1h-indolylsulfanyl)-benzyl amine derivatives as ssri |
01/17/2007 | CN1897976A Antagonists of the bradykinin b1 receptor |
01/17/2007 | CN1897953A Anti-inflammatory agents |
01/17/2007 | CN1897941A Alkylamino, arylamino, and sulfonamido cyclopentyl amide modulators of chemokine receptor activity |
01/17/2007 | CN1897929A Pharmaceutical composition comprising 5-methyl-2-(2'-chloro-6'-fluoroanilino)phenylacetic acid |
01/17/2007 | CN1896104A Fused protein for cell inhibitory factor and albumin |
01/17/2007 | CN1896076A Tricyclic-type compound, and medicine having it as effective component |
01/17/2007 | CN1895673A The use of substituted tetracyclic imidazole derivatives as anti-histaminics |
01/17/2007 | CN1895672A Multifunctional broad-spectrum obtundent of polyphyletic synergistic and its use |
01/17/2007 | CN1895670A Soluble lymphotoxin-beta receptors and anti-lymphotoxin receptor and ligand antibodies, as therapeutic agents for the treatment of immunological diseases |
01/17/2007 | CN1895641A Medicinal preparation with blood-activating, anti-inflammatory and analgesic functions and its making method |
01/17/2007 | CN1895637A Yuanqi ostealgia preparation and its making method |
01/17/2007 | CN1895627A Ointment for treating tendon impediment and its preparation |
01/17/2007 | CN1895624A Externally-applied medicinal liquid for treating rheumatalgia and wound and its preparation |
01/17/2007 | CN1895577A Chinese-medicinal preparation for treating appendicitis |
01/17/2007 | CN1895566A Medicinal composition for treating wind cold and rheumatic headache |
01/17/2007 | CN1895560A Chinese medicine for treating rheumatosis and rheumatoid disease |
01/17/2007 | CN1895559A Chinese-medicinal preparation for treating neck, shoulder, waist and skelagia |
01/17/2007 | CN1895556A Preparation for treating rheumatosis |
01/17/2007 | CN1895549A Soothe tendons and activating-blood anodyne plaster |
01/17/2007 | CN1895517A Medicine for rheumatosis and its making method |
01/17/2007 | CN1895505A Medicine for treating rheumatoid disease |
01/17/2007 | CN1895497A Analgesic mixed with Chinese medicine |
01/17/2007 | CN1895492A Medicine for treating difficult menstruation and its preparation |